| Literature DB >> 31511042 |
Sigita Kazune1,2, Anastasija Caica3,4, Karina Volceka3,4, Olegs Suba5, Uldis Rubins3, Andris Grabovskis3.
Abstract
BACKGROUND: In patients with septic shock, the skin is often chosen for the evaluation of peripheral perfusion and oxygenation. Changes in skin microcirculatory vessel oxygen saturation and relative hemoglobin concentration can be described using a mottling score or captured with hyperspectral imaging. However, the effectiveness of the mottling score in assessing microcirculation remains to be shown. We hypothesize that the mottling score in patients with septic shock is related to skin microcirculatory perfusion indices quantified by hyperspectral imaging, biomarkers that reflect endothelium activation and damage, and clinical outcome.Entities:
Keywords: Hyperspectral imaging; Microcirculation; Sepsis; Tissue oxygenation
Mesh:
Substances:
Year: 2019 PMID: 31511042 PMCID: PMC6739999 DOI: 10.1186/s13054-019-2589-0
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Fig. 1Images of two septic shock patients at different stages of processing. Segmented images were generated by dividing the hyperspectral cube into clusters with similar spectral properties that correspond to the degree of blood pooling. Skin oxygen saturation maps were generated by calculating μHbSO2 for each pixel in the region imaged. Each pixel was colored according to its value. Homogenous skin oxygenation is observed in a patient with higher μHbSO2. In the case of low μHbSO2, significant heterogeneity is present
Patient demographic, hemodynamic, acid-base, and perfusion characteristics
| All patients, | 28-day survivors, | 28-day non-survivors, | ||
|---|---|---|---|---|
| Demographics | ||||
| Age (years) | 70 (62–78) | 69 (61–78) | 72 (58–77) | 0.31 |
| Male, | 39 (61%) | 14 (56%) | 0.81 | |
| APACHE II | 23 (18–27) | 21 (17–25) | 29 (23–33) | < 0.001 |
| SOFA | 9 (7–12) | 8 (6–10) | 12 (10–13) | < 0.001 |
| Mechanical ventilation | 32 (36%) | 17 (43%) | 15 (75%) | 0.03 |
| Source | ||||
| Respiratory | 2 (26%) | 11 (17%) | 12 (48%) | n/a |
| Abdominal | 31 (35%) | 26 (41%) | 5 (20%) | n/a |
| Urinary | 26 (29%) | 22 (34%) | 4 (16%) | n/a |
| Others | 9 (%) | 5 (8%) | 4 (16%) | n/a |
| Temperature (°C) | 37.3 (36.7–38.5) | 37.2 (36.8–38.4) | 37.4 (36.6–38.9) | 0.91 |
| Hematocrit (%) | 35 (29–39) | 33 (28–39) | 37 (32–39) | 0.23 |
| Hemoglobin (g/dL) | 12.3 (10.4–13.8) | 12.2 (10.4–13.8) | 12.4 (10.9–13.9) | 0.87 |
| Bilirubin (mcmol/L) | 17.5 (9.0–29.0) | 18 (10–32) | 15 (6–26) | 0.25 |
| Hemodynamics | ||||
| HR, beats/min | 100 (91–115) | 96 (91–103) | 102 (94–112) | 0.81 |
| MAP, mmHg | 75 (67–85) | 79 (68–85) | 71 (65–87) | 0.39 |
| CVP, mmHg | 8 (5–12) | 7 (6–11) | 9 (7–13) | 0.59 |
| Resuscitation before HSI | ||||
| Fluids, mL | 3360 (2525–3394) | 3552 (3164–3786) | 3290 (2518–3576) | 0.71 |
| Noradrenaline dose, mcg/kg/min | 0.11 (0.08–0.17) | 0.1 (0.06–0.14) | 0.15 (0.1–0.27) | 0.003 |
| Duration of noradrenaline infusion, h | 14 (5–23) | 14 (7–23) | 11 (3–21) | 0.23 |
| Dobutamine, | 9 (10%) | 6 (9%) | 3 (12%) | 0.85 |
| Dobutamine dose, mcg/kg/min | 9.2 (7.6–12.1) | 8.9 (7.8–12.1) | 9.5 (7.6–13.0) | 0.68 |
| Acid-base parameters | ||||
| pH (arterial) | 7.36 (7.28–7.47) | 7.39 (7.31–7.46) | 7.31 (7.21–7.37) | 0.007 |
| PaCO2, mmHg | 31 (27–36) | 30 (27–35) | 33 (29–37) | 0.18 |
| PaO2, mmHg | 93 (72–126) | 88 (69–120) | 107 (77–127) | 0.44 |
| PaO2/FiO2, mmHg | 250 (173–332) | 263 (195–374) | 191 (145–254) | 0.04 |
| Perfusion parameters | ||||
| Lactate, mmol/L | 2.3 (1.2–4.1) | 2.6 (1.9–4.2) | 3.7 (2.0–5.4) | 0.3 |
| Mottling score | 0 (0;4) | 0 (0;3) | 0 (0;4) | < 0.001 |
| 0 | 62 (69%) | 51 (80%) | 11 (40%) | n/a |
| 1 | 10 (11%) | 8 (13%) | 2 (8%) | n/a |
| 2 | 14 (16%) | 4 (6%) | 10 (40%) | n/a |
| 3 | 3 (3%) | 1 (2%) | 2 (8%) | n/a |
| 4 | 1 (1%) | 0 | 1 (4%) | n/a |
Values are expressed as median (interquartile range) or count (percentage). Mottling score is reported as median (range)
APACHE II Acute Physiology, Age, Chronic Health Evaluation II; SOFA Sequential Organ Failure Assessment; n/a not applicable
Fig. 2Skin microcirculatory indices obtained from hyperspectral imaging according to mottling score. a Skin microcirculatory oxygen saturation, expressed as percentage, and b skin total hemoglobin concentration, expressed in arbitrary units (a.u.), according to the mottling score. Data are presented as the means ± standard error
Fig. 3a–f Relationship between mottling score and biomarkers of endothelial activation. Data are presented as means ± standard error
Fig. 4a–f Relationship between skin microcirculatory saturation and biomarkers of endothelial activation. Data are presented as the means ± standard error
Results of univariate analysis of the association between mottling score, skin microcirculatory oxygenation, and 28-day mortality
| Risk factor | Odds ratio | 95% CI | |
|---|---|---|---|
| Mottling score (0 as reference) | < 0.001 | ||
| 1 | 1.75 | 0.23–8.96 | 0.53 |
| 2 | 15.31 | 4.12–68.11 | < 0.001 |
| 3 | 18.37 | 2.07–398.52 | 0.02 |
| Skin microcirculatory saturation | 0.90 | 0.85–0.95 | < 0.001 |
CI confidence interval
Multivariate logistic regression model for an association between mottling score, skin microcirculatory indices, and 28-day mortality
| Variable | Odds ratio | 95% CI | |
|---|---|---|---|
| Mottling score (0 as reference) | |||
| 1 | 1.77 | 0.22–19.30 | 0.61 |
| 2 | 0.16 | 0.02–1.42 | 0.11 |
| 3 | 0.07 | 0–6.42 | 0.29 |
| Skin microcirculatory saturation | 1.12 | 1.04–1.23 | 0.008 |
| Skin hemoglobin content | 0.84 | 0.62–1.07 | 0.20 |
| Thrombomodulin | 0.89 | 0.65–1.20 | 0.46 |
| Angiopoietin-2 | 1.07 | 0.99–1.16 | 0.10 |
| ICAM-1 | 1.00 | 1.0 | 0.89 |
| VCAM-1 | 1.00 | 1.0 | 0.24 |
| PAI-1 | 1.00 | 1.0 | 0.48 |
| Syndecan-1 | 1.00 | 0.99–1.01 | 0.98 |
| SOFA score | 0.64 | 0.41–0.92 | 0.03 |
CI confidence interval, ICAM-1 intracellular adhesion molecule-1, VCAM-1 vascular cell adhesion molecule-1, PAI-1 plasminogen activator inhibitor-1, SOFA Sequential Organ Failure Assessment